A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 10 2023
Historique:
medline: 27 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Lung cancer is the leading cause of cancer deaths. Its high mortality is associated with high metastatic potential. Here, we show that the RAC1-selective guanine nucleotide exchange factor T cell invasion and metastasis-inducing protein 1 (TIAM1) promotes cell migration and invasion in the most common subtype of lung cancer, non-small-cell lung cancer (NSCLC), through an unexpected nuclear function. We show that TIAM1 interacts with TRIM28, a master regulator of gene expression, in the nucleus of NSCLC cells. We reveal that a TIAM1-TRIM28 complex promotes epithelial-to-mesenchymal transition, a phenotypic switch implicated in cell migration and invasion. This occurs through H3K9me3-induced silencing of protocadherins and by decreasing E-cadherin expression, thereby antagonizing cell-cell adhesion. Consistently, TIAM1 or TRIM28 depletion suppresses the migration of NSCLC cells, while migration is restored by the simultaneous depletion of protocadherins. Importantly, high nuclear TIAM1 in clinical specimens is associated with advanced-stage lung adenocarcinoma, decreased patient survival, and inversely correlates with E-cadherin expression.

Identifiants

pubmed: 37748077
doi: 10.1073/pnas.2300489120
pmc: PMC10556593
doi:

Substances chimiques

Protocadherins 0
Cadherins 0
TRIM28 protein, human EC 2.3.2.27
Tripartite Motif-Containing Protein 28 EC 2.3.2.27
TIAM1 protein, human 0
T-Lymphoma Invasion and Metastasis-inducing Protein 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300489120

Subventions

Organisme : Cancer Research UK
ID : A20465
Pays : United Kingdom

Références

Curr Biol. 2010 Apr 13;20(7):669-75
pubmed: 20346677
Curr Opin Cell Biol. 2007 Oct;19(5):584-92
pubmed: 17936607
Cancer Res. 2017 Oct 15;77(20):5445-5451
pubmed: 28807941
PLoS One. 2013 Dec 18;8(12):e82241
pubmed: 24367507
Cancer Metastasis Rev. 2016 Mar;35(1):75-91
pubmed: 27018053
Nat Rev Clin Oncol. 2015 Sep;12(9):511-26
pubmed: 25963091
Cancer Cell. 2017 May 8;31(5):621-634.e6
pubmed: 28416184
Small GTPases. 2017 Apr 3;8(2):90-99
pubmed: 27314616
Nat Commun. 2016 Feb 18;7:10664
pubmed: 26887924
J Biomed Sci. 2017 Aug 29;24(1):63
pubmed: 28851455
J Biol Chem. 2011 Jul 29;286(30):26267-76
pubmed: 21652716
Neuron. 2005 Feb 17;45(4):525-38
pubmed: 15721239
J Biol Chem. 2003 Feb 14;278(7):5132-40
pubmed: 12446731
Genes Dev. 2002 Apr 15;16(8):919-32
pubmed: 11959841
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7618-23
pubmed: 15128949
Cell Death Dis. 2018 Jan 18;9(2):27
pubmed: 29348665
N Engl J Med. 2021 Jun 24;384(25):2371-2381
pubmed: 34096690
Nat Commun. 2016 Oct 11;7:13048
pubmed: 27725632
Mod Pathol. 2009 May;22(5):668-78
pubmed: 19270647
Sci Transl Med. 2012 Jul 11;4(142):142ra95
pubmed: 22786680
Nat Commun. 2015 Jun 16;6:7437
pubmed: 26078008
Mol Cell Neurosci. 2005 Aug;29(4):603-16
pubmed: 15964765
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Development. 2013 Aug;140(16):3297-302
pubmed: 23900538
Diagn Pathol. 2014 Mar 24;9:69
pubmed: 24661909
Cell Rep. 2021 Nov 9;37(6):109979
pubmed: 34758330
Mol Cell. 2009 Mar 13;33(5):639-53
pubmed: 19285946
Cancer Epidemiol. 2013 Feb;37(1):71-8
pubmed: 22959342
Crit Rev Oncol Hematol. 2018 Apr;124:29-36
pubmed: 29548483
Cancer Res. 2007 Sep 1;67(17):8089-94
pubmed: 17804720
Small GTPases. 2017 Jul 3;8(3):139-163
pubmed: 27442895
PLoS One. 2014 Jul 01;9(7):e101040
pubmed: 24983967
Science. 1997 Nov 21;278(5342):1464-6
pubmed: 9367959
Clin Cancer Res. 2020 Nov 15;26(22):5962-5973
pubmed: 32900796
Cell Mol Life Sci. 2009 Feb;66(3):370-4
pubmed: 19151919
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Ann Oncol. 2019 May;30(5):863-870
pubmed: 31987360
Nat Commun. 2021 Mar 22;12(1):1808
pubmed: 33753749
Nat Cell Biol. 2012 Nov;14(11):1169-80
pubmed: 23103911
J Cell Sci. 2021 Apr 1;134(7):
pubmed: 33758078
Cell Cycle. 2011 May 15;10(10):1571-81
pubmed: 21478669
Mol Med Rep. 2018 Jan;17(1):835-842
pubmed: 29115614
Neuron. 2008 Dec 10;60(5):818-31
pubmed: 19081377
Biochem Soc Trans. 2020 Dec 18;48(6):2703-2719
pubmed: 33200195
Clin Cancer Res. 2020 Apr 1;26(7):1633-1643
pubmed: 31776128
N Engl J Med. 2021 Jun 24;384(25):2382-2393
pubmed: 34161704
J Pathol. 2018 Jun;245(2):222-234
pubmed: 29537081
J Cell Biol. 2018 Feb 5;217(2):447-457
pubmed: 29233866
J Intern Med. 2021 May;289(5):629-635
pubmed: 33340175
Oncogene. 2015 Dec 3;34(49):5971-82
pubmed: 25746002
Nat Cell Biol. 2002 Aug;4(8):621-5
pubmed: 12134164
J Biol Chem. 2004 Jul 16;279(29):30092-8
pubmed: 15138270
Genome Res. 2001 Mar;11(3):389-404
pubmed: 11230163
Mol Cancer Res. 2013 Mar;11(3):230-9
pubmed: 23322732
Curr Opin Cell Biol. 2018 Oct;54:50-56
pubmed: 29723737
Proc Natl Acad Sci U S A. 2023 Oct 3;120(40):e2300489120
pubmed: 37748077
Nat Genet. 2017 Aug;49(8):1239-1250
pubmed: 28671686
Nature. 2002 Jun 20;417(6891):867-71
pubmed: 12075356
Mol Cell Biol. 2005 Jun;25(11):4602-14
pubmed: 15899863
Transl Lung Cancer Res. 2016 Jun;5(3):288-300
pubmed: 27413711

Auteurs

Lucy Ginn (L)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Joe Maltas (J)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Martin J Baker (MJ)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Anshuman Chaturvedi (A)

The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom.

Leah Wilson (L)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Ryan Guilbert (R)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Fabio M R Amaral (FMR)

Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Lynsey Priest (L)

The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom.

Holly Mole (H)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom.

Fiona Blackhall (F)

The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom.
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom.

Zoi Diamantopoulou (Z)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Tim C P Somervaille (TCP)

Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Adam Hurlstone (A)

Division of Immunology, Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom.

Angeliki Malliri (A)

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH